While IL-17A is produced by CD4+ Th17 cells, it is involved in neutrophilia, inflammation, tissue destruction, and repair through the control of regulatory molecules (programmed death-1/programmed death ligand-1) and is also related to reverse reaction (RR) episodes in leprosy patients [40,41,42]. This evidence concerns the gene IL17A and leprosy.